News

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...
Eli Lilly reported impressive data at the recent American Diabetes Association ('ADA') conference. Its robust pipeline will ...
Business Insider spoke to Eli Lilly's new president of cardiometabolic health, who shared the company's aggressive incretin ...
The drugmaker has become a clear winner with its weight-loss drugs. Now, with a pill under development, the company should see earnings gains through the end of the decade.
The U.S. Food and Drug Administration approved changing the prescribing information for Eli Lilly's Alzheimer's drug Kisunla to allow more gradual dosing to lower the risk of a potentially dangerous ...
The latest international Eli Lilly and Co news and views from Reuters - one of the world's largest news agencies ...
See the latest Eli Lilly and Co stock price (LLY:XNYS), related news, valuation, dividends and more to help you make your investing decisions.
Review Eli Lilly and Co (LLY:XNYS) stock and the current sustainability and ESG risk rating to help with your investing decisions.
The NFL coaching carousel spins faster for coordinators. Some years, half the NFL makes changes on offense or defense. Although this title is relatively modern, it has its roots in decades past. Here ...